Ya-Ming Meng
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
- Oncology 4
- Chemokine receptors and signaling 2
- Cancer Cells and Metastasis 1
-
- Angiogenesis and VEGF in Cancer 2
- Glycosylation and Glycoproteins Research 1
- Sphingolipid Metabolism and Signaling 1
- Co-authors
- Limin Zheng (3 shared papers)Xing-Juan Yu (3 shared papers)Jing Xu (3 shared papers)Xiangzhan Kong (4 shared papers)Ping‐Pui Wong (4 shared papers)Xiaoyi Qiu (3 shared papers)Liangping Su (3 shared papers)Chao Liu (3 shared papers)
- Journals
- Molecular Therapy — Oncolytics (1 paper)Clinical Cancer Research (1 paper)Cell (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Ya-Ming Meng
11 papers receiving 531 citations
Peers
Comparison fields: 5 of 52
- Cancer Research 117
- Oncology 173
- Immunology 135
- Hepatology 28
- Obstetrics and Gynecology 25
Countries citing papers authored by Ya-Ming Meng
This map shows the geographic impact of Ya-Ming Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya-Ming Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya-Ming Meng more than expected).
Fields of papers citing papers by Ya-Ming Meng
This network shows the impact of papers produced by Ya-Ming Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya-Ming Meng. The network helps show where Ya-Ming Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Ya-Ming Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 146 | |
| 2 | 2021 | 102 | |
| 3 | 2020 | 75 | |
| 4 | 2017 | 48 | |
| 5 | 2017 | 39 | |
| 6 | 2021 | 39 | |
| 7 | 2020 | 38 | |
| 8 | 2022 | 23 | |
| 9 | 2023 | 15 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 3 |
About Ya-Ming Meng
Ya-Ming Meng is a scholar working on Oncology, Molecular Biology, Immunology and Allergy, Obstetrics and Gynecology and Hepatology, having authored 11 papers that have together received 534 indexed citations. Recurring topics across this work include Chemokine receptors and signaling (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Cancer Mechanisms and Therapy (1 paper), Glycosylation and Glycoproteins Research (1 paper), Cell Adhesion Molecules Research (1 paper), Cancer Cells and Metastasis (1 paper), Cancer Research and Treatments (1 paper) and Sphingolipid Metabolism and Signaling (1 paper). The work is most often cited by research in Cancer Research (117 citations), Oncology (173 citations), Immunology (135 citations), Hepatology (28 citations) and Obstetrics and Gynecology (25 citations). Ya-Ming Meng has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Limin Zheng, Xing-Juan Yu, Jing Xu, Xiangzhan Kong, Ping‐Pui Wong, Xiaoyi Qiu, Liangping Su, Chao Liu, Cheng Huang and Xinbao Zhao. Their work appears in journals such as Molecular Therapy — Oncolytics, Clinical Cancer Research, Cell, Journal for ImmunoTherapy of Cancer and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.